Outcomes of colonoscopy with non-anesthesiologist-administered propofol (NAAP): an equivalence trial.

 Efficacy and safety of NAAP for gastrointestinal endoscopy have been widely documented, although there is no information about the outcomes of colonoscopy when the endoscopist supervises the sedation. In this context, the aim of this trial was to determine the equivalence of adenoma detection rate (ADR) in colorectal cancer (CRC) screening colonoscopies performed with non-anesthesiologist-administered propofol (NAAP) and performed with monitored anesthesia care (MAC). This was a single-blind, non-randomized controlled equivalence trial that enrolled adults from a national CRC screening program (CRCSP).

[Essential quality criteria in the indication and performance of colonoscopy].

Colonoscopy is the gold standard for the diagnosis and treatment of diseases of the colon and, especially, for screening and surveillance of colorectal cancer. Because of the rapid and progressive rise in the number of procedures performed in the last few years and the inherent risks of this increase, quality criteria for the indication and performance of this procedure are required. These criteria should be standardized for all endoscopists and endoscopy units; moreover, continual evaluation of the staff and units performing this procedure should be carried out.